Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001387131-19-005124
Filing Date
2019-07-16
Accepted
2019-07-16 20:29:08
Documents
2
Period of Report
2019-07-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 1597
2 POWER OF ATTORNEY ex24.htm EX-24 7397
  Complete submission text file 0001387131-19-005124.txt   10532
Mailing Address
Business Address
GOLDSTEIN DOV A MD (Reporting) CIK: 0001120478 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-35963 | Film No.: 19958096

Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations